The trial will be commencing enrollment in July 2021 for patients who have colorectal cancer that has spread to the liver. The purpose of the trial is to administer a treatment called Liver Isolation Oxaliplatin (LIOX). This treatment uses a new medical device called AVAS® that isolates the liver and administers the chemotherapy drug, Oxaliplatin directly into the organ.
